CY1105656T1 - Χρηση ανθρωπινου υποδοχεα προσομοιαζοντος με λατροφιλινη και συζευγμενου με g -πρωτεϊνη σε μεθοδους διαλογης - Google Patents
Χρηση ανθρωπινου υποδοχεα προσομοιαζοντος με λατροφιλινη και συζευγμενου με g -πρωτεϊνη σε μεθοδους διαλογηςInfo
- Publication number
- CY1105656T1 CY1105656T1 CY20061101459T CY061101459T CY1105656T1 CY 1105656 T1 CY1105656 T1 CY 1105656T1 CY 20061101459 T CY20061101459 T CY 20061101459T CY 061101459 T CY061101459 T CY 061101459T CY 1105656 T1 CY1105656 T1 CY 1105656T1
- Authority
- CY
- Cyprus
- Prior art keywords
- protein
- human
- receptor
- latrofilin
- mike
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 abstract 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 210000000750 endocrine system Anatomy 0.000 abstract 1
- 230000028023 exocytosis Effects 0.000 abstract 1
- 210000000653 nervous system Anatomy 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Αντιδραστήρια που ρυθμίζουν πρωτεΐνη ανθρώπινου υποδοχέα προσομοιάζοντος με λατροφιλίνη (latrophilin) και συζευγμένου με G-πρωτεΐνη (LT-GPCR) και αντιδραστήρια που δεσμεύονται με προϊόντα ανθρώπινου γονιδίου LT-GPCR μπορούν να παίζουν ρόλο σε αποτροπή, βελτίωση, ή διόρθωση δυσλειτουργιών ή νόσων που σχετίζονται με ανώμαλη εξωκυττάρωση στο ενδοκρινές σύστημα και στο νευρικό σύστημα.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19110300P | 2000-03-22 | 2000-03-22 | |
| US21074500P | 2000-06-12 | 2000-06-12 | |
| PCT/EP2001/003223 WO2001070969A2 (en) | 2000-03-22 | 2001-03-21 | Regulation of human latrophilin-like g protein-coupled receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1105656T1 true CY1105656T1 (el) | 2010-12-22 |
Family
ID=26886755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20061101459T CY1105656T1 (el) | 2000-03-22 | 2006-10-12 | Χρηση ανθρωπινου υποδοχεα προσομοιαζοντος με λατροφιλινη και συζευγμενου με g -πρωτεϊνη σε μεθοδους διαλογης |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040175698A1 (el) |
| EP (1) | EP1276867B1 (el) |
| AT (1) | ATE337398T1 (el) |
| AU (1) | AU2001263796A1 (el) |
| CY (1) | CY1105656T1 (el) |
| DE (1) | DE60122488T2 (el) |
| DK (1) | DK1276867T3 (el) |
| ES (1) | ES2271020T3 (el) |
| PT (1) | PT1276867E (el) |
| WO (1) | WO2001070969A2 (el) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003255459A1 (en) * | 2002-08-19 | 2004-03-11 | Bayer Healthcare Ag | Regulation of human secretin-type gpcr (latrophilin) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001229340A1 (en) * | 2000-01-14 | 2001-07-24 | Millennium Pharmaceuticals, Inc. | Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
-
2001
- 2001-03-21 AU AU2001263796A patent/AU2001263796A1/en not_active Abandoned
- 2001-03-21 PT PT01938027T patent/PT1276867E/pt unknown
- 2001-03-21 DE DE60122488T patent/DE60122488T2/de not_active Expired - Fee Related
- 2001-03-21 US US10/221,159 patent/US20040175698A1/en not_active Abandoned
- 2001-03-21 EP EP01938027A patent/EP1276867B1/en not_active Expired - Lifetime
- 2001-03-21 ES ES01938027T patent/ES2271020T3/es not_active Expired - Lifetime
- 2001-03-21 AT AT01938027T patent/ATE337398T1/de not_active IP Right Cessation
- 2001-03-21 DK DK01938027T patent/DK1276867T3/da active
- 2001-03-21 WO PCT/EP2001/003223 patent/WO2001070969A2/en active IP Right Grant
-
2006
- 2006-10-12 CY CY20061101459T patent/CY1105656T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1276867A2 (en) | 2003-01-22 |
| EP1276867B1 (en) | 2006-08-23 |
| US20040175698A1 (en) | 2004-09-09 |
| AU2001263796A1 (en) | 2001-10-03 |
| DE60122488D1 (de) | 2006-10-05 |
| WO2001070969A2 (en) | 2001-09-27 |
| PT1276867E (pt) | 2006-12-29 |
| WO2001070969A3 (en) | 2002-09-26 |
| ES2271020T3 (es) | 2007-04-16 |
| DK1276867T3 (da) | 2007-01-02 |
| DE60122488T2 (de) | 2007-10-04 |
| ATE337398T1 (de) | 2006-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69918946D1 (de) | Rezeptoren für il-18 | |
| CY1114919T1 (el) | Anti-mag ανθρωποποιημενα αντισωματα και οι χρησεις τους για την αντιμετωπιση του εγκεφαλικου επεισοδιου | |
| CY1108074T1 (el) | Ανοσολογικες μεθοδοι για τη ρυθμιση της μυοστατινης σε σπονδυλωτα | |
| DK203489A (da) | Anti-t-celle receptor determinanter til diagnosticering og behandling af autoimmune sygdomme | |
| FI963101A0 (fi) | Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut | |
| DK0692025T3 (da) | Gærceller, der er konstrueret således, at de producerer surrogater for proteiner i feromonsystemet, og anvendelser deraf | |
| CY1110416T1 (el) | Δικυκλικα παραγωγα ιμιδαζ-5-υλ-αμινης | |
| CO4290416A1 (es) | Antagonistas de receptores de taquicinas no-peptidos | |
| CY1107314T1 (el) | Μεθοδος θεpαπευτικης αγωγης ασθενων προσβεβλημενων με σκληρυνση κατα πλακας χρησιμοποιωντας συναινετικη ιντepφepονη | |
| NO308740B1 (no) | Kinazolinderivater, anvendelse derav og farmasøytisk blanding | |
| CY1105227T1 (el) | Ενωσεις πιπepιδινης ως αντιαλλepγικα | |
| HUP9702458A2 (hu) | Humán interleukin-1-receptor járulékos fehérje | |
| ATE247481T1 (de) | Neuartige peptidantagonisten der glutaminsäure- und nmda-rezeptoren | |
| PT840615E (pt) | Proteina de ligacao da quemoquina e metodos para a sua utilizacao | |
| DK0825857T3 (da) | Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse | |
| CY1105656T1 (el) | Χρηση ανθρωπινου υποδοχεα προσομοιαζοντος με λατροφιλινη και συζευγμενου με g -πρωτεϊνη σε μεθοδους διαλογης | |
| NO952828D0 (no) | Synergiserende blanding med en antagonist-virkning på NK1- og NK2-reseptorer | |
| DE59801230D1 (de) | Endothelin-rezeptorantagonisten zur bekämpfung von hyperlipidämie | |
| TR200100921T2 (tr) | Terkipler ve bunların mide-özofagus geri akım hastalığı için kullanımı | |
| HUP0100611A2 (hu) | Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére | |
| DK0751947T3 (da) | Glucosidderivater af N-acylalkylaminer, der udøver neurobeskyttende, neurotrop og anti-inflammatorisk virkning, og som er a | |
| DK0822986T3 (da) | Antagonister af human interleukin-6, der er fuldstændig ude af stand til at binde GP 130, og deres anvendelse til fremstilling af farmaceutiske forbindelser | |
| BR9812368A (pt) | 2-aminotetralinas, processo para sua preparação, e composições farmacêuticas, para a prevenção e tratamento terapêutico de patologias inflamatórias e/ou autoimunes | |
| DK0983361T3 (da) | Bakterielle pheromoner og anvendelser deraf | |
| CY1105675T1 (el) | Πρωτεϊνη ροσδενουσα αγγειοστατινη |